Vertical Graphene-Based Biosensor for Tumor Cell Dielectric Signature Evaluation

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Diagnostics

Background:

• Conventional tumor cell detection methods are time-consuming, costly, and prone to errors.
• Graphene nanomaterials offer revolutionary potential for specific and selective tumor cell capture.
• There is a need for advanced biosensors in the theranostic field for efficient cancer diagnosis.

Purpose of the Study:

• To develop and evaluate a novel electrochemical biosensor for the selective and rapid detection of tumor cells.
• To utilize graphene-based technology for enhanced tumor cell capture and differentiation.
• To establish a dielectric signature-based method for distinguishing between different cancer cell lines.

Main Methods:

• Fabrication of a biosensor using vertically aligned graphene nanosheets on interdigitated electrodes.
• Functionalization of the biosensor surface with anti-EpCAM antibodies for specific tumor cell targeting.
• Analysis of dielectric signatures, including Nyquist and Bode plots, to extract key electrical properties.
• Correlation of dielectric properties (e.g., permittivity, charge transfer resistance) with tumor cell types.

Main Results:

• The biosensor successfully differentiated between three distinct tumor cell lines (HT-29, SW403, MCF-7) based on their dielectric signatures.
• Key electrical parameters like charge transfer resistance and electrical double layer capacity varied significantly between cell lines.
• Permittivity measurements at 1 MHz provided distinct values for each cell line: 3.63 nF (SW403), 4.97 nF (HT-29), and 6.9 nF (MCF-7).

Conclusions:

• The developed graphene-based electrochemical biosensor enables rapid and selective tumor cell detection.
• Dielectric signature analysis is an effective method for differentiating between various cancer cell lines.
• This approach holds significant promise for advancing theranostic applications in cancer diagnosis.